General Information
edit

CAPNIA is a private company developing novel therapeutic products using its proprietary medical gas delivery system. We are targeting a number of chronic diseases treatable with topical application of well understood, safe and effective gas compounds. Our first product is entering Phase IIb clinical trials for the treatment of acute migraines and related symptoms. 28 million Americans and over 240 million people worldwide suffer from this debilitating condition.

Milestones
edit

CAPNIA received $19.2M in Series C funding. (4/24/08)

Posted 6/5/09 at 12:32am
CAPNIA added James R Butler as Senior Vice President, Marketing.

Posted 6/5/09 at 12:32am
CAPNIA added Ron Haak as Senior Vice President, Technology Development .

Posted 6/5/09 at 12:32am
CAPNIA added Anish Bhatnagar as Chief Medical Officer.

Posted 6/5/09 at 12:32am
CAPNIA added Ernest Mario as Chairman and CEO.

Posted 6/5/09 at 12:32am
CAPNIA added Gerard Pereira as Chief Business Officer and Chief Financial Officer.

Posted 6/5/09 at 12:32am